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ABSTRACT 
A 73-year-old man with short segmental Barrett’s esophagus underwent 
esophagoscopy, and a slightly depressed, discolored lesion was found on the anterior 
wall of lower esophagus. Under a provisional diagnosis of differentiated 
adenocarcinoma without local lymph node metastasis, endoscopic submucosal 
dissection (ESD) was performed. En bloc resection with tumor-free lateral/basal 
margins was accomplished without complications. The resected area was 12X15 mm 
in size, whereas the neoplastic lesion was 4X4 mm. Histopathological examination 
confirmed intramucosal well-differentiated tubular adenocarcinoma without 
angiolymphatic invasion adjacent to the muscularis mucosae. Repeated 
esophagoscopy 6 months after ESD showed neither locally recurrent nor 
metachronous lesions. Considering that Barrett’s esophagus is a precancerous 
condition, one may recommend eradication of both the neoplastic and 
non-neoplastic lesion with employing ESD.  
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INTRODUCTION 
Surgical treatment is still recommended in patients with Barrett’s esophagus (BE) 
with high-grade intraepithelial neoplasia or early carcinoma limited to the mucosa. 
However, surgical mortality and postoperative morbidity, although decreasing, 
continue to be significant [1]. In recent years, the use of endoscopic techniques to 
deal with such incipient lesions in BE has increased [2]. Superficial BE cancers are 
not usually associated with locoregional lymph node involvement or distant 
metastasis [1,2]. Therefore, local treatment can provide a reasonable expectation of 
cure. 
Endoscopic submucosal dissection (ESD) is an endoscopic resection method 
for superficial gastric cancers that was developed in Japan [3]. ESD involves 
circumferential cutting of the mucosa that surrounds the tumor, followed by 
dissection of the submucosa under the lesion. Using this method, almost any 
mucosal tumor, regardless of size and shape, can be resected en bloc. Recently, ESD 
has been used in other parts of the gastrointestinal tract, including the esophagus and 
colorectum [4, 5, 6]. However, its use in superficial BE cancers is still limited. 
 73-year-old man had upper gastrointestinal endoscopy for slight anemia (Hb 13 
g/dL); all other laboratory test results were within normal limits. His physical 
examination, as well as past and family histories, was non-contributory. On upper 
endoscopy, he was found to have a short segmental BE. Endoscopic recognition of 
BE was made by identification of the proximal margin of the gastric folds as the 
landmark. The palisade-shaped longitudinal vessels, which may be of value as 
esophageal landmark, were overlaid with the columnar-lined epithelia. Discolored 
flat mucosa on the anterior wall of the lower esophagus was identified within the 
columnar-lined epithelia (Figure 1A). The palisade-shaped longitudinal vessels, 
which may be of value as esophageal landmark, were overlaid with the 
columnar-lined epithelia of the other area. However, the palisade-shaped 
longitudinal vessels were invisible in the discolored area. On chromoendoscopy with 
indigo carmine (Figure 1B), a slightly depressed lesion was seen within the 
discolored area, and it was classified as a IIb+IIc type. Differentiated 
adenocarcinoma was suspected on the endoscopic biopsies. Endoscopic ultrasound 
and computed tomography excluded local lymph node metastasis. Thus, endoscopic 
submucosal dissection (ESD) was done (Figure 2). The lesion was lifted with 
submucosal injection of a glycerin and fructose solution. Then, a circumferential 
incision of the surrounding non-neoplastic mucosa was made using a Flex-knife 
(Olympus, Tokyo, Japan) with a high-frequency generator set at 80 W, while the 
Hook-knife (Olympus) was employed for ESD (output 60 W). En bloc resection 
with tumor-free lateral/basal margins was accomplished without complications. The 
resected area was 12X15 mm, whereas the neoplastic lesion was 4X4 mm (Figure 3). 
An esophageal gland was found in the submucosa layer just under the cancer lesion 
resected (Figure 4). The histopathological examination confirmed the diagnosis of an 
intramucosal well-differentiated tubular adenocarcinoma adjacent to the muscularis 
mucosae without angiolymphatic invasion (Figure 5A). On immunostaining, the 
neoplasm was positive for p53 (Figure 5B). Repeat esophagoscopy 6 months after 
ESD showed neither recurrent nor metachronous lesions (Figure 6).  
 
DISCUSSION 
Endoscopic treatment, including endoscopic mucosal resection (EMR) and ESD, is 
an alternative to esophagectomy in BE patients with superficial neoplasms due to 
the low risk of lymph node involvement or distal metastases [1]. Endotherapy 
maximizes functional and organ preservation [2]. However, EMR has limitations 
with respect to the resectable tumor size; in many cases, piecemeal resection is 
unavoidable and has been occasionally linked to local recurrence [7]. ESD was first 
developed for en bloc removal of large gastric neoplasms. Recently, ESD has been 
used to remove esophageal squamous neoplasms or esophagogastric junction tumors 
including BE neoplasms with promising results [4,5]. It has been reported that the 
complete en bloc resection rate of ESD for esophagogastric junction tumors was no 
less than 97% (29/30) [5]. Perforation occurred in one case, but was safely managed 
by rotatable clips. In our case, the intramucosal adenocarcinoma was successfully 
removed using ESD without any complications, such as perforation and bleeding. In 
line with our experience, Kakushima et al. described the complete removal of BE 
cancer lesions in 4 series [5]. Given these encouraging results, ESD should be more 
often considered as the primary treatment for superficial BE neoplasms. However, 
controlled studies comparing ESD and esophagectomy are needed.  
We used several methods to minimize complications. First, a transparent 
hood was attached to the endoscope tip to ensure a good view during ESD. Second, 
to avoid perforation, a glycerin and fructose solution was injected to achieve higher 
and more sustained submucosal elevation. Finally, the operator was skilled in ESD 
and had considerable experience using ESD for relatively uncomplicated gastric 
tumors. Thus, ESD could be safely performed in patients with early BE cancer.  
EMR is a treatment modality for early cancer of small size 1cm or less in diameter. 
For larger lesions, however, EMR is associated with risk of remnant disease or local 
recurrence [7]. Indeed the cancer lesion resected was 4x4mm in size, but the extent of the 
cancer lesion could not be exactly detected on endoscopic observation. We could not help 
but resect the affected lesion with sufficient lateral margin using ESD in order to prevent 
local recurrent disease. The whole resected area by ESD was 12x15mm in size, which 
included the cancer lesion with surrounding non-neoplastic columnar epithelia. Patients 
with a diagnosis of Barrettﾕs esophagus are thought to be at risk of developing high-grade 
dysplasia or esophageal adenocarcinoma [1]. In Western countries, some endoscopists have 
performed circumferential piecemeal EMR for not only mucosal Barrettﾕs cancer but also 
surrounding non-neoplastic Barrett’s mucosa in order to prevent local recurrence or the 
development of metachronous neoplastic lesions, albeit this concept is still controversial [8]. 
In principle, the ESD procedure may be used to eradicate the whole BE area, though this 
would be technically challenging. Further assessment of case series is necessary to evaluate 
the occurrence of complications, including post-ESD stenosis.  
In Asia, including Japan, BE and its related neoplasm used to be less 
common than in Western countries [9]. However, in recent years, the number of 
reported cases of BE and its related neoplasm has increased in Japan [9]. 
Adenocarcinoma of the esophagus is still rare in Asia, although the annual death rate 
from adenocarcinoma of the esophagus has increased from 3.7 (1960) to 6.9 (1995) 
per 100,000 population [9]. Clearly, continued surveillance of changes in the 
epidemiology of BE and adenocarcinoma of the esophagus is needed. Furthermore, 
thorough observation of patients with risk factors for BE neoplasms using 
chromoendoscopy and/or magnifying endoscopy would contribute to the early 
detection of neoplasms, as seen in our case.  
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Figure 1. A: On upper endoscopy, discolored flat mucosa on the anterior wall of the 
lower esophagus was identified within the columnar-lined Barrett’s epithelia. The 
palisade-shaped longitudinal vessels were overlaid with the columnar-lined epithelia 
of the other area, whereas the palisade-shaped longitudinal vessels were invisible in 
the discolored area. B: On chromoendoscopy with indigo carmine, a slightly 
depressed lesion was seen within the discolored area, and it was classified as a 
IIb+IIc type. 
Figure 2. Endoscopic submucosal dissection (ESD) was performed successfully. 
Figure 3. The resected macroscopic specimen. A red line indicated the cancer lesion.  
Figure 4. An esophageal gland was found in the submucosa layer just under the cancer 
lesion resected.  
Figure 5. A: The histopathological examination shows a well-differentiated, 
intramucosal tubular adenocarcinoma adjacent to the muscularis mucosae without 
angiolymphatic invasion. B: On immunostaining, the neoplasm glands are positive 
for p53. 
Figure 6. Repeat esophagoscopy 6 months after ESD showed neither recurrent nor 
metachronous lesions. 
